Question 1

Is Carbidopa-Monohydrate currently in shortage?

Accepted Answer

Yes. As of the latest regulator updates, Carbidopa-Monohydrate has 15 active shortage notices across 5 countries (Australia, United States, Canada, Italy, Peru). Status is refreshed daily from official regulatory sources.

Question 2

Why is Carbidopa-Monohydrate in shortage?

Accepted Answer

Regulators attribute the current Carbidopa-Monohydrate shortages to product discontinuation, causes not stated by the regulator, manufacturing problems. The exact cause varies by country and product — each notice on this page links to the official source.

Question 3

When will the Carbidopa-Monohydrate shortage be resolved?

Accepted Answer

Regulator-estimated resolution dates currently range from 31 May 2021 to 1 Sept 2026, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.

Question 4

Where does this Carbidopa-Monohydrate shortage data come from?

Accepted Answer

Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.

Country	Severity	Notices	Since	Est. resolution	Source
Australia	high	4	16 Mar 2026	1 Sept 2026	TGA
United States	high	1	7 Oct 2025	—	FDA MedWatch

Carbidopa-Monohydrate shortage status

Where Carbidopa-Monohydrate is in shortage

Why Carbidopa-Monohydrate is in shortage

Recent shortage history

Frequently asked questions

Get alerted when Carbidopa-Monohydrate status changes